Yuhan Corporation benefits from growing overseas demand

Despite its voluntary withdrawal of a popular brand Contac 600 containing controversial phenylpropanolamine (PPA) from the market in August, Yuhan Corporation said its stocks have risen 20.5 percent in the third quarter, significantly outperforming the broader benchmark KOSPI.

Amid the sluggish pharmaceutical business at home, Yuhan has benefited from growing overseas demand, particularly in...